Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.

CSE:RVV - Post by User

Revive Therapeutics Ltd.

Bullboard Posts

Comment by larooon Apr 20, 2017 8:29pm

129 Views

Post# 26146446

RE:RE:RE:RE:InMed

cloreenbaconskin wrote: Because Inmed is currently being pumped by the Wolf of Weed Street and many others just like VIN was a few months ago.

Been in InMed for a couple years and made amazing $$ in the last month's run up. No clue what propelled it or what is keeping it strong but Im not going to look a gift horse in the mouth.While its true they did obv spend some cash and or shares to the likes of Wolf for self promotion they were also written up by Forbes and included in a prestigious article today by Bloomberg. If you are correct and this is the only thing that rocketed InMed then maybe RVV should spend a few bucks and do the same thing. Danny Deadlock doesnt seem to be having the same impact on the sp here despite his recent attempts.

As far as waiting for the RVV InMed term sheet news, I can see that being much more of a positive for InMed than RVV imo. The first announcement did wonders for RVV and virtually nothing for IN strangely. After all it is RVV that will be paying for and providing validation for InMed's bioinformatics system. At any rate, I am hopeful RVV will release some sort of news shortly that will jumpstart the sp again.